Gene · 406940
Papers4,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miRNA and lncRNA as potential tissue biomarkers in hepatocellular carcinoma. | Noncoding RNA Res | 2024 | 38075204 | PubTator, text mining | PubMed |
| Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review). | Int J Oncol | 2024 | 38038050 | PubTator, text mining | PubMed |
| miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targets. | Noncoding RNA Res | 2024 | 38035044 | PubTator, text mining | PubMed |
| Single‑cell sequencing, genetics, and epigenetics reveal mesenchymal stem cell senescence in osteoarthritis (Review). | Int J Mol Med | 2024 | 37937669 | PubTator, text mining | PubMed |
| miR-206 alleviates LPS-induced inflammatory injury in cardiomyocytes via directly targeting USP33 to inhibit the JAK2/STAT3 signaling pathway. | Mol Cell Biochem | 2024 | 37256445 | PubTator, text mining | PubMed |
| MicroRNA-mediated Regulation of LDL Receptor: Biological and Pharmacological Implications. | Curr Med Chem | 2024 | 37026494 | PubTator, text mining | PubMed |
| MicroRNA profile of extracellular vesicles released by Müller glial cells. | Front Cell Neurosci | 2023 | 38303973 | PubTator, text mining | PubMed |
Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota. | Front Immunol | 2023 | 38288125 | PubTator, text mining | PubMed |
| The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity. | Front Immunol | 2023 | 38264670 | PubTator, text mining | PubMed |
| Circular RNAs and inflammation: Epigenetic regulators with diagnostic role. | Pathol Res Pract | 2023 | 38238072 | PubTator, text mining | PubMed |
| Application of microfluidic technology based on surface-enhanced Raman scattering in cancer biomarker detection: A review. | J Pharm Anal | 2023 | 38223444 | PubTator, text mining | PubMed |
| The Expression Patterns and Implications of MALAT1, MANCR, PSMA3-AS1 and miR-101 in Esophageal Adenocarcinoma. | Int J Mol Sci | 2023 | 38203269 | PubTator, text mining | PubMed |
| Clinical Biofluid Assays for Prostate Cancer. | Cancers (Basel) | 2023 | 38201592 | PubTator, text mining | PubMed |
| Molecular Insight into Gastric Cancer Invasion-Current Status and Future Directions. | Cancers (Basel) | 2023 | 38201481 | PubTator, text mining | PubMed |
| The role of ncRNA regulatory mechanisms in diseases-case on gestational diabetes. | Brief Bioinform | 2023 | 38189542 | PubTator, text mining | PubMed |
| Altered expression of miR-125a and dysregulated cytokines in systemic lupus erythematosus: Unveiling diagnostic and prognostic markers. | World J Exp Med | 2023 | 38173550 | PubTator, text mining | PubMed |
| Exploring the theranostic potentials of miRNA and epigenetic networks in autoimmune diseases: A comprehensive review. | Immun Inflamm Dis | 2023 | 38156400 | PubTator, text mining | PubMed |
| Understanding the Immunological Quality of Breast Milk in Maternal Overweight and Obesity. | Nutrients | 2023 | 38140275 | PubTator, text mining | PubMed |
| COVID-19 Vaccination in Pregnancy: Pilot Study for Maternal and Neonatal MicroRNA Profiles. | Vaccines (Basel) | 2023 | 38140218 | PubTator, text mining | PubMed |
| Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer. | Int J Mol Sci | 2023 | 38139352 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406940/papers?page=8